Hi all,
The recording of this IDG presentation on 'Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates' is now available to view on demand here: Link
Thanks!
Rob & Todd
------------------------------
Robert Nelson
Scientific Officer, Senior Director
BioAgilytix Europe GmbH
Hamburg Germany
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
------------------------------
Original Message:
Sent: 08-30-2024 10:17
From: Todd Lester
Subject: Immunogenicity Discussion Group - Sept 4th | 12pm EDT
Join us for the next Immunogenicity Discussion Group on Wednesday, September 4th at 12pm EDT.
We will host a presentation and discussion with @Arkadeep Sinha and @Mallory Souliotis, co-authors on the recent publication: Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates (https://doi.org/10.1080/17576180.2024.2366091).
They will explore case studies on interference from domain-specific confirmatory reagents and an assay where target interference eluded detection until validation.
Submit your email address to receive a personal Teams meeting calendar invite: Submit Email Address.
Cheers!
Todd & Rob
------------------------------
Todd Lester
BioAgilytix | Senior Director
Durham, NC | [email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------